Cell Medica: Transforming patients live through cellular immunotherapy




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Cell Medica: Transforming patients live through cellular immunotherapy
Released on: August 15, 2017. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Cell Medica is committed to transforming the treatment of cancer through the use of cellular immunotherapy.
  • Summary
  • Transcript
  • Participants
  • Company
Cell Medica is committed to transforming the treatment of cancer through the use of cellular immunotherapy. Through our internal development and collaborations and with leading academic research groups, we are working with three powerful technology platforms to generate safe and effective treatments to address a range of cancer types. Our goal is to develop curative cell-based therapies that can be used safely and reliably for the benefit of patients. Summer Park talks with Dr Kurt Gunter, Chief Medical Officer of Cell Medica about their approach to cancer treatments
Cell Medica is committed to transforming the treatment of cancer through the use of cellular immunotherapy. Through our internal development and collaborations and with leading academic research groups, we are working with three powerful technology platforms to generate safe and effective treatments to address a range of cancer types. Our goal is to develop curative cell-based therapies that can be used safely and reliably for the benefit of patients. Summer Park talks with Dr Kurt Gunter, Chief Medical Officer of Cell Medica about their approach to cancer treatments
Dr Kurt Gunter
Cell Medica is committed to transforming the treatment of cancer through the use of cellular immunotherapy. Through our internal development and collaborations and with leading academic research groups, we are working with three powerful technology platforms to generate safe and effective treatments to address a range of cancer types. Our goal is to develop curative cell-based therapies that can be used safely and reliably for the benefit of patients. Summer Park talks with Dr Kurt Gunter, Chief Medical Officer of Cell Medica about their approach to cancer treatments